Isolated testicular vasculitis due to immune checkpoint inhibitor

Isolated testicular vasculitis due to immune checkpoint inhibitor

Bibliographic Details
Main Authors:	Rebecca Weiner, Britt Hanson, Jamaal Rehman, Bob Sun
Format:	Article
Language:	English
Published:	AVES Yayincilik 2020-01-01
Series:	European Journal of Rheumatology
Online Access:	https://www.eurjrheumatol.org/en/isolated-testicular-vasculitis-due-to-immune-checkpoint-inhibitor-133268

Similar Items

Immune checkpoint inhibitor-related acral vasculitis
by: Thibault Comont, et al.
Published: (2018-11-01)

Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor Pembrolizumab
by: Hideo Oishi, MD, et al.
Published: (2020-10-01)

Thyroid Dysfunctions Due to Immune Checkpoint Inhibitors: A Review
by: El Sabbagh R, et al.
Published: (2020-11-01)

Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis
by: Chie Miyabe, et al.
Published: (2021-10-01)

Testicular granulomatous vasculitis mimicking testicular torsion in an anti-neutrophil cytoplasmic antibody–associated vasculitis patient
by: Liye Suo, et al.
Published: (2019-01-01)

Immune Checkpoint Inhibitors and the Heart
by: Diana Larisa Mocan-Hognogi, et al.
Published: (2021-09-01)

Testicular Vasculitis: A Sonographic and Pathologic Diagnosis
by: Anuj Dixit, et al.
Published: (2017-01-01)

Testicular vasculitis: a series of 19 cases
by: Athanase Billis
Published: (2011-04-01)

Immune Checkpoint Inhibitors New Insights and Recent Progress
Published: (2023)

Tumour-immune dynamics with an immune checkpoint inhibitor
by: Elpiniki Nikolopoulou, et al.
Published: (2018-06-01)

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
by: Yi-Te Huang, et al.
Published: (2020-07-01)

Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors
by: Alexey Youssef, et al.
Published: (2018-01-01)

Chronic immune checkpoint inhibitor pneumonitis
by: Joanne Riemer, et al.
Published: (2020-06-01)

Immune Checkpoint Inhibitors in Special Populations
by: Qianyun Shan, et al.
Published: (2021-08-01)

Immune Checkpoint Inhibitors in the Treatment of HCC
by: Clelia Donisi, et al.
Published: (2021-01-01)

Management of Immune Checkpoint Inhibitor Toxicities
by: Durrechou Q, et al.
Published: (2020-09-01)

Ipilimumab (Immune Checkpoint Inhibitors) Hypophysitis
by: Margot Stagnetto, et al.
Published: (2020-11-01)

Indicators of responsiveness to immune checkpoint inhibitors
by: Bradley D. Shields, et al.
Published: (2017-04-01)

Cardiotoxicity from immune checkpoint inhibitors
by: Lars Michel, et al.
Published: (2019-12-01)

Clinical Development of Immune Checkpoint Inhibitors
by: Ayumu Ito, et al.
Published: (2015-01-01)

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
by: Shigehisa Kitano, et al.
Published: (2018-07-01)

Immune checkpoint inhibitors for urothelial carcinoma
by: Hyung Suk Kim, et al.
Published: (2018-09-01)

Immune Checkpoint Inhibitors in Prostate Cancer
by: Shobi Venkatachalam, et al.
Published: (2021-05-01)

Immune Checkpoint Inhibitor-Associated Myocarditis
by: Grigorios Chatzantonis, MD, et al.
Published: (2020-04-01)

Immune Checkpoint Inhibitors for the Therapy of Thymoma
by: Alicia Quilez, MD, et al.
Published: (2020-03-01)

Cardiovascular complications of immune checkpoint inhibitors
by: A. A. Kulievа, et al.
Published: (2020-04-01)

Cardiotoxicity and Mechanisms of Immune Checkpoint Inhibitors
by: DONG Shuang, et al.
Published: (2018-11-01)

Immune Checkpoint Inhibitors in the Treatment of Lymphomas
by: KV Lepik
Published: (2018-10-01)

The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors
by: Zhaozhen Wu, et al.
Published: (2021-02-01)

Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors
by: Mariana Mirabel, MD, PhD, et al.
Published: (2020-09-01)

Immune Checkpoints Contribute Corneal Immune Privilege: Implications for Dry Eye Associated with Checkpoint Inhibitors
by: Junko Hori, et al.
Published: (2020-05-01)

Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma
by: Evan Lipson, et al.
Published: (2020-07-01)

Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer
by: Liu W, et al.
Published: (2020-07-01)

Pulmonary Complications Secondary to Immune Checkpoint Inhibitors
by: Hasan Ahmad Hasan Albitar, et al.
Published: (2020-01-01)

Immune checkpoint inhibitor-associated celiac disease
by: Mari Mino-Kenudson, et al.
Published: (2020-06-01)

Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
by: Katarina Hradska, et al.
Published: (2021-08-01)

Correction: Chronic immune checkpoint inhibitor pneumonitis
by: Erika J Crosby, et al.
Published: (2020-07-01)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
by: Amina Ghouzlani, et al.
Published: (2021-07-01)

Clinical Insights Into Novel Immune Checkpoint Inhibitors
by: Jii Bum Lee, et al.
Published: (2021-05-01)

Immune-Checkpoint Inhibitors in B-Cell Lymphoma
by: Marc Armengol, et al.
Published: (2021-01-01)